Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × OTHER × mirdametinib × Clear all

Phase

Status

Recruiting 6 Completed 5 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Drug Therapy 106 Cisplatin 98 Carboplatin 88 Radiotherapy 83 Bevacizumab 81 Oxaliplatin 73 Capecitabine 71 tislelizumab 69 Cyclophosphamide 65 Gemcitabine 64 toripalimab 61 Paclitaxel 61 pembrolizumab 56 sintilimab 55 Surgical Procedures, Operative 51 Fluorouracil 49 Specimen Handling 47 Magnetic Resonance Spectroscopy 45 Immune Checkpoint Inhibitors 45 130-nm albumin-bound paclitaxel 44 anlotinib 43 Radiosurgery 38 lenvatinib 37 Standard of Care 37 Blood Specimen Collection 37 camrelizumab 35 fludarabine 31 Leucovorin 31 Immunotherapy 31 Docetaxel 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡